Allelic losses of multiple chromosome loci in gastric adenocarcinoma suggest that inactivation of tumour suppressor genes in these regions may be important for tumourigenesis. To define deletion intervals and find candidate tumour suppressor genes involved in gastric adenocarcinoma pathogenesis, a genome-wide search for loss of heterozygosity (LOH) was conducted in 45 patients with primary gastric adenocarcinoma. Investigations using 29 microsatellite markers spanning chromosomes 17 and 18 showed allelic deletion in 29 (64%) specimens at one or more loci. Five LOH overlap regions, three newly identified as deletion regions, were defined: RI, D17S831–D17S921 at 17p12-13.3; RII, D17S1868–D17S787 at 17q21.3-22; RIII, D17S785–D17S928 at 17q25.3; RIV, D18S61–D18S1161 at 18q22; and RV, D18S462–D18S70 at 18q22-q23. Eleven (24%) patients with chromosome 17 allelic loss also showed LOH on 18q, with at least one region of overlapping. LOH mapping showed allelic losses were widespread on both chromosomes and suggests the possibility that multiple tumour suppressor genes, including one or more that are unknown, might be inactivated in the aetiology of gastric adenocarcinoma.
PanCJLiuKY: Proliferation/apoptosis and expression of p53 and Bcl-2 in gastric carcinoma. Shi Jie Hua Ren Xiao Hua Za Zhi2003; 11: 526–530.
2.
KobayashiMKawashimaAMaiM: Analysis of chromosome 17p13 (p53 locus) alterations in gastric carcinoma cells by dual-color fluorescence in situ hybridization. Am J Pathol1996; 149: 1575–1584.
3.
Fenoglio-PreiserCMWangJStemmermannGN: TP53 and gastric carcinoma: A review. Hum Mutat2003; 21: 258–270.
4.
SembaSYokozakiHYasuiW: Frequent microsatellite instability and loss of heterozygosity in the region including BRCA1(17q21) in young patients with gastric cancer. Int J Oncol1998; 12: 1245–1251.
5.
PettyEMKalikinLMOrringerMB: Distal chromosome 17q loss in Barrett's esophageal and gastric cardia adenocarcinomas: Implications for tumorigenesis. Mol Carcinog1998; 22: 222–228.
6.
NishiokaNYashiroMInoueT: A candidate tumor suppressor locus for scirrhous gastric cancer at chromosome 18q12.2. Int J Oncol2001; 18: 317–322.
7.
NishizukaSTamuraGMaesawaC: Analysis of the DPC4 gene in gastric carcinoma. Jpn J Cancer Res1997; 88: 335–339.
8.
SatoKTamuraGTsuchiyaT: Frequent loss of expression without sequence mutations of the DCC gene in primary gastric cancer. Br J Cancer2001; 85: 199–203.
9.
InoueTUchinoSShiraishiN: Loss of heterozygosity on chromosome 18q in cohesive-type gastric cancer is associated with tumor progression and poor prognosis. Clin Cancer Res1998; 4: 973–977.
10.
de ManzoniGTomezzoliADi LeoA: Clinical significance of mutator phenotype and chromosome 17p and 18q allelic loss in gastric cancer. Br J Surg2001; 88: 419–425.
11.
RoyDCalafGHeiTK: Frequent allelic imbalance on chromosome 6 and 17 correlate with radiation-induced neoplastic transformation of human breast epithelial cells. Carcinogenesis2001; 22: 1685–1692.
12.
KuboHMikiCKusunokiM: Evaluation of genetic mutations of tumor suppresser genes in colorectal cancer patients. Hepatogastro-enterology2004; 51: 114–117.
13.
KoJMWongCPTangCM: Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas. Cancer Lett2001; 170: 131–138.
14.
VeltmanJAvan WeertIAubeleM: Specific steps in aneuploidization correlate with loss of heterozygosity of 9p21, 17p13 and 18q21 in the progression of pre-malignant laryngeal lesions. Int J Cancer2001; 91: 193–199.
15.
ChaeKSRyuBKLeeMG: Expression and mutation analyses of MKK4, a candidate tumour suppressor gene encoded by chromosome 17p, in human gastric adenocarcinoma. Eur J Cancer2002; 38: 2048–2057.
16.
SuGHHilgersWShekherMC: Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. Cancer Res1998; 58: 2339–2342.
17.
TsuchiyaETanigamiAIshikawaY: Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer. Jpn J Cancer Res2000; 91: 589–596.
18.
PhillipsNJZieglerMRRadfordDM: Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res1996; 56: 606–611.
19.
NigroCLVenesioTReymondA: The human ROX gene: Genomic structure and mutation analysis in human breast tumors. Genomics1998; 49: 275–282.
20.
Steichen-GersdorfEBaumgartnerMKreczyA: Deletion mapping on chromosome 17p in medulloblastoma. Br J Cancer1997; 76: 1284–1287.
21.
WangDFangDLouY: A study on the loss of heterozygosity at 17p13.3 and abnormal expression of p53 protein in gastric carcinoma. Zhonghua Bing Li Xue Za Zhi1997; 26: 134–136.
22.
SchultzDCVanderveerLBermanDB: Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res1996; 56: 1997–2002.
23.
FujiiHBielMAZhouW: Methylation of HIC-1 candidate tumor suppressor gene in human breast cancer. Oncogene1998; 16: 2159–2164.
24.
WalesMMBielMADeiryWE: p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat Med1995; 1: 570–577.
25.
NigroCLVenesioTReymondA: The human ROX gene: Genomic structure and mutation analysis in human breast tumors. Genomics1998; 49: 275–282.
26.
GleesonCMSloanJMMcManusDT: Comparison of p53 and DNA content abnormalities in adenocarcinoma of the oesophagus and gastric cardia. Br J Cancer1998; 77: 277–286.
27.
FongKMKidaYZimmermanPV: Loss of heterozygosity frequently affects chromosome 17q in non-small cell lung cancer. Cancer Res1995; 55: 4268–4272.
28.
CampoEMiquelRJaresP: Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas. Cancer1994; 73: 2913–2921.
29.
JiSQHuaYWZhuangJ: Significance of COX-2, p53, proliferating cell nuclear antigen and nm23 expressions in gastric cancer and its behavior. Ai Zheng2002; 21: 619–624.
30.
WuCLKirleySDXiaoH: Cables enhances cdk2 tyrosine 15 phosphorylation by Wee1, inhibits cell growth, and is lost in many human colon and squamous cancers. Cancer Res2001; 61: 7325–7332.
31.
TanDKirleySLiQ: Loss of cables protein expression in human non-small cell lung cancer: A tissue microarray study. Hum Pathol2003; 34: 143–149.
32.
CandussoMELuinettiOVillaniL: Loss of heterozygosity at 18q21 region in gastric cancer involves a number of cancer-related genes and correlates with stage and histology, but lacks independent prognostic value. J Pathol2002; 197: 44–50.
33.
ZhuYQYinHRZhuZG: Loss of heterozygosity of SMAD4/DPC4 in gastric carcinoma. Shi Jie Hua Ren Xiao Hua Za Zhi2003; 11: 522–525.
34.
TakebayashiSOgawaTJungKY: Identification of new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res2000; 60: 3397–3403.
35.
LassusHSalovaaraRAaltonenLA: Allelic analysis of serous ovarian carcinoma reveals two putative tumor suppressor loci at 18q22-q23 distal to SMAD4, SMAD2, and DCC. Am J Pathol2001; 159: 35–42.
